These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19284354)

  • 1. The current infectious risks of transfusions.
    Marques A; Torres S; Davis JM
    Surg Infect (Larchmt); 2005; 6 Suppl 1():S23-31. PubMed ID: 19284354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging infectious threats to the blood supply.
    Dodd RY; Leiby DA
    Annu Rev Med; 2004; 55():191-207. PubMed ID: 14746517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted infectious diseases.
    Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
    Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging viral diseases and infectious disease risks.
    Tapper ML
    Haemophilia; 2006 Mar; 12 Suppl 1(Suppl 1):3-7; discussion 26-8. PubMed ID: 16445811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of transfusion-transmitted infections: 2003.
    Pomper GJ; Wu Y; Snyder EL
    Curr Opin Hematol; 2003 Nov; 10(6):412-8. PubMed ID: 14564170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates.
    Corash L
    Vox Sang; 2000; 78 Suppl 2():205-10. PubMed ID: 10938954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections.
    Stramer SL
    ISBT Sci Ser; 2014 Jul; 9(1):30-36. PubMed ID: 25210533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
    Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
    Andersen O
    Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
    [No Abstract]   [Full Text] [Related]  

  • 11. Verses, viruses, and the vulnerability of the blood supply in industrialized countries.
    Mushahwar IK
    J Med Virol; 2007 Aug; 79(8):1229-37. PubMed ID: 17596828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging infectious disease issues in blood safety.
    Chamberland ME; Alter HJ; Busch MP; Nemo G; Ricketts M
    Emerg Infect Dis; 2001; 7(3 Suppl):552-3. PubMed ID: 11485669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging infections in transfusion medicine.
    Fiebig EW; Busch MP
    Clin Lab Med; 2004 Sep; 24(3):797-823, viii. PubMed ID: 15325065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of pathogen reduction technology for therapeutic plasma.
    Chakrabarty P; Rudra S; Hoque MM
    Mymensingh Med J; 2010 Apr; 19(2):308-11. PubMed ID: 20395932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?
    Chamberland ME
    Clin Infect Dis; 2002 Mar; 34(6):797-805. PubMed ID: 11850862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bitten by a bug or a bag? Transfusion-transmitted dengue: a rare complication in the bleeding surgical patient.
    Oh HB; Muthu V; Daruwalla ZJ; Lee SY; Koay ES; Tambyah PA
    Transfusion; 2015 Jul; 55(7):1655-61. PubMed ID: 25728040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reacting to an emerging safety threat: West Nile virus in North America.
    Stramer SL
    Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.